Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.295
-0.035 (-2.63%)
At close: May 12, 2025
-51.68%
Market Cap 97.84M
Revenue (ttm) 30.49M
Net Income (ttm) -37.36M
Shares Out 77.96M
EPS (ttm) -0.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 103,261
Average Volume 73,108
Open 1.320
Previous Close 1.330
Day's Range 1.150 - 1.320
52-Week Range 0.720 - 2.960
Beta 0.97
RSI 48.58
Earnings Date Apr 25, 2025

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography r... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 30
Stock Exchange Nordic Growth Market
Ticker Symbol BIOWKS
Full Company Profile

Financial Performance

In 2024, Bio-Works Technologies AB's revenue was 30.49 million, a decrease of -30.55% compared to the previous year's 43.90 million. Losses were -37.36 million, -34.25% less than in 2023.

Financial Statements

News

There is no news available yet.